European Lithium’s Greenland Permit Delay Tests Merger Timetable and Cash Position

The rare earth developer is in a holding pattern. Its pilot plant in Qaqortoq, Greenland, sits ready, built by contractor 60° North Greenland, but the machinery remains idle pending final sign-off from regulators in Nuuk. The company had targeted a May start for operations, but the delay means the planned 150?tonne bulk sampling campaign is now slated for June — assuming the green light arrives in time. The project’s metallurgical tests in March delivered a strong signal: the lab confirmed a recovery rate above 85% for all eight target rare earth elements, a sharp improvement over historical data.

That technical achievement has strategic weight. Heavy rare earths are critical for electric motors and defence applications, markets long dominated by China. The Tanbreez project has already drawn interest from the US Export-Import Bank, which has extended a non?binding letter of intent for up to US$120 million in financing. The 150?tonne rock sample, once extracted, is earmarked for potential offtakers in Europe, the US and Saudi Arabia — though securing that sample requires a separate export certificate from Greenlandic authorities.

On the corporate front, European Lithium is navigating a more complex puzzle. The proposed merger with Critical Metals Corp., valued at roughly US$835 million and intended to deliver a Nasdaq listing, hit a procedural snag. The binding Scheme Implementation Deed was due to be signed by 7 May; that deadline passed without a signature. Both parties have extended the exclusivity period to finalise the legal framework, while the commercial terms remain unchanged: EUR shareholders will receive 0.035 new CRML shares per existing share, and ASX option holders will be compensated based on intrinsic option value.

Should investors sell immediately? Or is it worth buying European Lithium?

Financially, the company faces a gap of A$24 million. One of the merger’s conditions requires European Lithium to hold net liquidity of at least A$330 million at completion. As of late March, its cash balance stood at A$306 million. Complicating matters, the exclusivity agreement prevents the company from raising new equity or debt. How that shortfall will be closed is unclear. Meanwhile, Morgan Stanley and related entities have sold their entire reportable stake, and a buyback programme is underway: the company can repurchase up to 10% of issued shares for a maximum of A$12.6 million until mid?October, with the shares subsequently cancelled.

Austria adds another layer of difficulty. The Federal Administrative Court has overturned a key environmental permit for the Wolfsberg lithium project in Carinthia, ordering a stricter, case?by?case review. The final investment decision there has been pushed back to late 2026. The mining licence remains valid until early 2028, and the offtake agreement with BMW is unchanged, but the legal setback has clearly stalled progress.

The stock has still rallied hard — up roughly 205% year?to?date, trading at A$0.440. But the share price now faces a triple test: the Greenland permit must arrive to unlock the summer sampling campaign, the cash gap needs to be bridged without violating the exclusivity terms, and the merger documentation must be signed. If those pieces fall into place, shareholders will vote on the deal in the third quarter of 2026. Until then, the fate of European Lithium rests on a single letter from Nuuk — and a bank balance that is just a few million short of the line.

Ad

European Lithium Stock: New Analysis - 13 May

Fresh European Lithium information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated European Lithium analysis...

en | AU000000EUR7 | EUROPEAN | boerse | 69327286 |